Biotech · Private company
RenovoRx
Track this companyFree. Adds RenovoRx to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- GemcitabinePhase 3 · Locally Advanced Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- nab-paclitaxelPhase 3 · Locally Advanced Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- RenovoCathPhase 3 · Locally Advanced Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- Gemcitabine, local deliveryPhase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- RenovoCath®Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- RenovoCath™ R120 CatheterPancreatic NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- PumaRx Registry TrialRECRUITING · started Aug 1, 2025ClinicalTrials.gov NCT06805461 · fetched Nov 12, 2026
- Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 12, 2018ClinicalTrials.gov NCT03257033 · fetched Nov 12, 2026
- Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 CatheterCOMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02591082 · fetched Nov 12, 2026
- A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic CancerPHASE1 · COMPLETED · started Mar 1, 2015ClinicalTrials.gov NCT02237157 · fetched Nov 12, 2026